p53-Luc/EF1α-mCherry Reporter Cell Line - HEK293

The p53-Luc/EF1α-mCherry Reporter Cell Line - HEK293 is a genetically engineered human embryonic kidney 293 cell line designed for sensitive monitoring of p53 pathway activity. In this dual-reporter system, firefly luciferase expression is driven by a p53-responsive promoter, providing a quantitative luminescent readout of p53 transcriptional activation. The constitutively expressed mCherry fluorescent protein is controlled by the human EF1α promoter and serves as a stable internal marker for cell identification, imaging, transfection assessment, and normalization of cell number or viability. Because HEK293 cells are highly transfectable, robust in culture, and suitable for a broad range of molecular biology workflows, this reporter line offers a convenient cellular platform for evaluating p53-dependent signaling. Activation of p53 by DNA damage, oxidative stress, oncogene signaling, or pharmacological treatment can induce luciferase activity, while changes in mCherry fluorescence may help distinguish pathway-specific effects from nonspecific cytotoxicity or loss of cell viability.

This reporter cell line is highly valuable for screening and analyzing small molecules, biologics, gene-editing reagents, and nucleic acid-based therapeutics capable of modulating the p53 pathway. It can be employed in high- or medium-throughput screening for p53 activators, inhibitors of the MDM2-p53 interaction, DNA-damaging agents, and compounds that suppress aberrant p53 signaling. Furthermore, researchers can utilize this system to investigate upstream regulators of p53, such as kinases, phosphatases, ubiquitin ligases, and transcriptional cofactors. In the field of cancer research, this cell line serves as a practical tool for characterizing the pharmacodynamic effects of candidate anticancer drugs and for comparing pathway responses under various experimental conditions.